A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993
Clinical trial NCT06508762 · COMPLETED
Trial details
- NCT number
- NCT06508762
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-26
- Primary completion
- 2024-09-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.